The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved TMC Pharma's fosdenopterin (Nulibry) for the treatment of molybdenum cofactor deficiency (MoCD) type A. This rare ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...